InsiderTrades.com logo
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
From Traders Agency   |   Ad
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Click here now for the full details of this stock that’s set to rocket in the AI revolution…

THRX Insider Trading

Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 46.70%
Insider Buying (Last 12 Months): $3,542,792.60
Insider Selling (Last 12 Months): $0.00

Theseus Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Theseus Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Theseus Pharmaceuticals Share Price & Price History

Current Price: $4.06
Price Change: +0.30 (1.20%)
As of 02/14/2024 01:00 AM ET

This chart shows the closing price history over time for THRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
The only accurate crypto trading system I know …
From Weiss Ratings   |   Ad
Juan Villaverde is no ordinary crypto trader. His proprietary timing algorithm has led him to rack up a series of gains of 477%, 333% and 153% on Bitcoin … It pointed the way to Cardano, at just 4 cents …Helping investors make 29 times their money.
Here's what our expert says you should buy before April 14.

Theseus Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/17/2023Carl L. GordonDirectorBuy479,932$3.05$1,463,792.6017,063,000View SEC Filing Icon  
7/17/2023Foresite Capital Management V,Major ShareholderBuy700,000$2.97$2,079,000.004,108,796View SEC Filing Icon  
11/30/2022Bradford D. DahmsCFOBuy1,502$6.66$10,003.326,142View SEC Filing Icon  
11/7/2022Carl L. GordonDirectorBuy192,000$5.21$1,000,320.0016,734,518View SEC Filing Icon  
1/21/2022Carl L. GordonDirectorBuy111,896$9.97$1,115,603.12View SEC Filing Icon  
1/19/2022Carl L. GordonDirectorBuy11,521$9.97$114,864.37View SEC Filing Icon  
1/13/2022Carl L. GordonDirectorBuy17,320$9.43$163,327.60View SEC Filing Icon  
1/11/2022Carl L. GordonDirectorBuy8,500$10.51$89,335.00View SEC Filing Icon  
12/21/2021Bradford D. DahmsCFOBuy1,970$10.15$19,995.50View SEC Filing Icon  
12/21/2021Timothy P. ClacksonCEOBuy2,600$9.76$25,376.00View SEC Filing Icon  
See Full Table
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
From Traders Agency   |   Ad
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Click here now for the full details of this stock that’s set to rocket in the AI revolution…

SEC Filings (Institutional Ownership Changes) for Theseus Pharmaceuticals (NASDAQ:THRX)

91.05% of Theseus Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at THRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Theseus Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2024Frazier Life Sciences Management L.P.2,118,051$8.58M0.5%-5.8%4.789%Search for SEC Filing on Google Icon
2/15/2024Beryl Capital Management LLC288,887$1.17M0.6%N/A0.653%Search for SEC Filing on Google Icon
2/14/2024ADAR1 Capital Management LLC174,715$0.71M0.3%N/A0.395%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC 9,302$38K0.0%+62.2%0.021%Search for SEC Filing on Google Icon
2/12/2024MMCAP International Inc. SPC277,303$1.12M0.2%N/A0.627%Search for SEC Filing on Google Icon
2/12/2024Highbridge Capital Management LLC616,860$2.50M0.1%N/A1.395%Search for SEC Filing on Google Icon
2/6/2024AJOVista LLC9,520$39K0.0%N/A0.022%Search for SEC Filing on Google Icon
2/2/2024BML Capital Management LLC1,108,320$4.49M3.4%N/A2.506%Search for SEC Filing on Google Icon
1/30/2024BML Capital Management LLC1,108,317$4.49M3.5%N/A2.506%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio46,300$0.19M0.0%+1,614.8%0.105%Search for SEC Filing on Google Icon
1/19/2024Denali Advisors LLC103,800$0.42M0.1%-18.8%0.235%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC13,212$54K0.0%N/A0.030%Search for SEC Filing on Google Icon
1/5/2024Exchange Traded Concepts LLC48,510$0.20M0.0%+34.0%0.110%Search for SEC Filing on Google Icon
11/15/2023Laurion Capital Management LP171,157$0.46M0.0%-4.7%0.393%Search for SEC Filing on Google Icon
11/15/2023Affinity Asset Advisors LLC400,726$1.08M0.3%+66.8%0.919%Search for SEC Filing on Google Icon
11/14/2023Lynx1 Capital Management LP702,415$1.89M1.2%-7.2%1.611%Search for SEC Filing on Google Icon
11/13/2023Foresite Capital Management V LLC4,108,796$11.05M17.6%+14.6%9.424%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC259,470$0.70M0.0%N/A0.595%Search for SEC Filing on Google Icon
11/8/2023Forefront Analytics LLC17,672$48K0.0%N/A0.041%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc213,896$0.58M0.0%+100.0%0.491%Search for SEC Filing on Google Icon
10/20/2023Denali Advisors LLC127,900$0.34M0.1%+675.2%0.293%Search for SEC Filing on Google Icon
10/18/2023Exchange Traded Concepts LLC36,210$97K0.0%+144.8%0.083%Search for SEC Filing on Google Icon
8/21/2023Affinity Asset Advisors LLC240,244$2.24M0.8%+144.6%0.551%Search for SEC Filing on Google Icon
8/15/2023HighVista Strategies LLC136,719$1.28M0.6%N/A0.314%Search for SEC Filing on Google Icon
8/14/2023Driehaus Capital Management LLC232,693$2.17M0.0%+2.9%0.534%Search for SEC Filing on Google Icon
8/8/2023Candriam S.C.A.270,015$2.52M0.0%-16.6%0.620%Search for SEC Filing on Google Icon
8/7/2023Principal Financial Group Inc.10,679$100K0.0%N/A0.025%Search for SEC Filing on Google Icon
8/2/2023Bank of Montreal Can277,074$2.80M0.0%N/A0.636%Search for SEC Filing on Google Icon
7/20/2023Exchange Traded Concepts LLC14,791$0.14M0.0%N/A0.034%Search for SEC Filing on Google Icon
7/18/2023Denali Advisors LLC16,500$0.15M0.1%N/A0.038%Search for SEC Filing on Google Icon
5/16/2023Fairmount Funds Management LLC1,865,671$16.57M2.8%N/A4.281%Search for SEC Filing on Google Icon
5/16/2023Altium Capital Management LP112,614$1M0.6%N/A0.258%Search for SEC Filing on Google Icon
5/16/2023Boxer Capital LLC350,000$3.11M0.2%-15.7%0.803%Search for SEC Filing on Google Icon
5/15/2023Affinity Asset Advisors LLC98,221$0.87M0.3%N/A0.225%Search for SEC Filing on Google Icon
5/10/2023Tekla Capital Management LLC75,000$0.67M0.0%-25.0%0.172%Search for SEC Filing on Google Icon
5/3/2023Jump Financial LLC15,859$0.14M0.0%N/A0.036%Search for SEC Filing on Google Icon
2/14/2023Boxer Capital LLC415,000$2.07M0.1%-53.5%1.072%Search for SEC Filing on Google Icon
2/13/2023Foresite Capital Management V LLC3,585,346$17.86M13.9%+7.5%9.262%Search for SEC Filing on Google Icon
2/10/2023Opaleye Management Inc.535,000$2.66M0.9%+142.5%1.382%Search for SEC Filing on Google Icon
2/3/2023Frazier Life Sciences Management L.P.1,398,194$6.96M0.4%N/A3.612%Search for SEC Filing on Google Icon
11/15/2022Farallon Capital Management LLC223,149$1.29M0.0%-45.5%0.576%Search for SEC Filing on Google Icon
11/14/2022Forefront Analytics LLC13,065$74K0.0%N/A0.034%Search for SEC Filing on Google Icon
8/16/2022Woodline Partners LP211,684$1.17M0.0%-15.3%0.547%Search for SEC Filing on Google Icon
8/16/2022DAFNA Capital Management LLC81,899$0.45M0.1%+2.2%0.212%Search for SEC Filing on Google Icon
8/15/2022Opaleye Management Inc.32,300$0.18M0.1%N/A0.083%Search for SEC Filing on Google Icon
8/12/2022Ensign Peak Advisors Inc142,598$0.79M0.0%-43.0%0.368%Search for SEC Filing on Google Icon
8/8/2022Walleye Capital LLC31,719$0.18M0.0%N/A0.082%Search for SEC Filing on Google Icon
8/4/2022TD Asset Management Inc.106,948$0.59M0.0%+59.3%0.276%Search for SEC Filing on Google Icon
5/10/2022TD Asset Management Inc.67,133$0.77M0.0%+19.4%0.173%Search for SEC Filing on Google Icon
5/5/2022New York State Common Retirement Fund9,495$0.11M0.0%+475.1%0.025%Search for SEC Filing on Google Icon
2/19/2022Woodline Partners LP250,000$3.17M0.0%N/A0.646%Search for SEC Filing on Google Icon
2/15/2022Laurion Capital Management LP205,021$2.60M0.0%N/A0.530%Search for SEC Filing on Google Icon
2/15/2022Lynx1 Capital Management LP409,358$5.19M4.5%N/A1.058%Search for SEC Filing on Google Icon
2/15/2022Adage Capital Partners GP L.L.C.761,589$9.66M0.0%N/A1.968%Search for SEC Filing on Google Icon
2/14/2022Boxer Capital LLC892,057$11.31M0.4%N/A2.305%Search for SEC Filing on Google Icon
2/14/2022Nextech Invest AG611,310$7.75M1.8%N/A1.579%Search for SEC Filing on Google Icon
2/14/2022DAFNA Capital Management LLC97,500$1.24M0.3%N/A0.252%Search for SEC Filing on Google Icon
2/14/2022Omega Fund Management LLC711,479$9.02M1.3%N/A1.838%Search for SEC Filing on Google Icon
2/11/2022Foresite Capital Opportunity Management V LLC468,820$5.95M4.0%N/A1.211%Search for SEC Filing on Google Icon
2/11/2022Ensign Peak Advisors Inc250,000$3.17M0.0%N/A0.646%Search for SEC Filing on Google Icon
2/10/2022TD Asset Management Inc.56,202$0.71M0.0%N/A0.145%Search for SEC Filing on Google Icon
2/8/2022Northern Trust Corp96,884$1.23M0.0%N/A0.250%Search for SEC Filing on Google Icon
1/24/2022Strs Ohio2,700$34K0.0%N/A0.007%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Theseus Pharmaceuticals logo
Theseus Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted therapies for the treatment of cancer patients. Its lead product candidate is THE-630, a pan-KIT inhibitor for the treatment of gastrointestinal stromal tumors. The company also develops THE-349, a fourth-generation selective epidermal growth factor receptor inhibitor to address C797X-mediated resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer. Its development programs address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer. The company was incorporated in 2017 and is based in Cambridge, Massachusetts. As of February 14, 2024, Theseus Pharmaceuticals, Inc. operates as a subsidiary of Concentra Biosciences, LLC.
Read More on Theseus Pharmaceuticals

Today's Range

Now: $4.06
Low: $4.06
High: $4.06

50 Day Range

MA: $4.06
Low: $4.06
High: $4.07

52 Week Range

Now: $4.06
Low: $2.05
High: $12.37

Volume

N/A

Average Volume

592,167 shs

Market Capitalization

$179.57 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.98

Who are the company insiders with the largest holdings of Theseus Pharmaceuticals?

Theseus Pharmaceuticals' top insider shareholders include:
  1. Carl L Gordon (Director)
  2. Foresite Capital Management V, (Major Shareholder)
  3. Bradford D Dahms (CFO)
Learn More about top insider investors at Theseus Pharmaceuticals.
top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)
From Traders Agency   |   Ad
AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.
Click here now for the full details of this stock that’s set to rocket in the AI revolution…